(RTTNews) - Sonnet BioTherapeutics Holdings, Inc. (SONN), Tuesday said it has appointed one of its directors Raghu Rao as interim chief executive officer after the company's founder and CEO Pankaj ...

Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, of Sonnet discuss the recently announced safety data related to SON-1010 - Watch the "What This Means ...

As part of the segment, Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, discussed the recently announced positive safety results of SON-1010 (IL12-F H AB) at ...